These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24830277)

  • 1. Don't exclude community pharmacists.
    Hoey BD
    Mod Healthc; 2014 Mar; 44(10):26. PubMed ID: 24830277
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlights of the Medicare Prescription Drug Act.
    Conomikes GS
    J Okla State Med Assoc; 2005 Oct; 98(10):492-3. PubMed ID: 16296207
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction. Update on pharmaceutical reimbursement and implications for health-system pharmacists .
    Johnson PE
    Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S2-3. PubMed ID: 18192244
    [No Abstract]   [Full Text] [Related]  

  • 6. Plastic price cuts? Drug discount cards shave but don't slash high bills. And most aren't free.
    Comarow A
    US News World Rep; 2002 Apr; 132(12):74-6. PubMed ID: 11974551
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicare disadvantaged and the search for the elusive 'level playing field'.
    Berenson RA
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-572-85. PubMed ID: 15601664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceuticals and medical devices: Medicare Part D. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447
    [No Abstract]   [Full Text] [Related]  

  • 9. Perspectives. Lower premiums? Medicare PPOs? Don't bet on it, analysts say.
    Med Health; 2004 Jun; 58(25):1, 7-8. PubMed ID: 15283500
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prescription for a modern Medicare program.
    Bach PB; McClellan MB
    N Engl J Med; 2005 Dec; 353(26):2733-5. PubMed ID: 16382056
    [No Abstract]   [Full Text] [Related]  

  • 12. Geography and destiny: local-market perspectives on developing Medicare Advantage regional plans.
    Hurley RE; Strunk BC; Grossman JM
    Health Aff (Millwood); 2005; 24(4):1014-21. PubMed ID: 16012141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current issues in pharmaceutical reimbursement.
    Fijalka S; Fye D; Johnson PE
    Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S11-26. PubMed ID: 18192243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death of pharmacy or safer dispensing?
    McNee W
    N Z Med J; 2003 May; 116(1174):U446. PubMed ID: 12766788
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicare codes coming for telehealth, preventive care.
    Marbury D
    Med Econ; 2013 Aug; 90(15):54-5. PubMed ID: 24730110
    [No Abstract]   [Full Text] [Related]  

  • 16. Take this Medicare risk readiness test for '98.
    Public Sect Contract Rep; 1998 Jan; 4(1):1-5. PubMed ID: 10177371
    [No Abstract]   [Full Text] [Related]  

  • 17. Don't get burned by risky Medicare point-of-service.
    Public Sect Contract Rep; 1997 Apr; 3(4):49-55. PubMed ID: 10174866
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical reimbursement: an overview.
    Johnson PE
    Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S4-10. PubMed ID: 18192246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective design: regional competition in Medicare.
    Pizer SD; Feldman R; Frakt AB
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-399-411. PubMed ID: 16118247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rural perspective regarding regulations implementing Titles I and II of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA).
    Mueller C; Mueller K; Sutton J
    Policy Anal Brief W Ser; 2004 Aug; (6):1-19. PubMed ID: 15529473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.